Senseonics Holdings, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| SENS | NPCE | DXCM | TCMD | SGHT | 0YX.F | |
|---|---|---|---|---|---|---|
| Market cap | 476.92M | 457.89M | 33.00B | 608.87M | 533.25M | 6.53B |
| P/E (TTM) | — | — | 34.8 | 26.4 | — | 31.0 |
| Forward P/E | -4.6 | -61.3 | 28.2 | 18.5 | -24.2 | — |
| Price/book | 5.3 | 38.4 | 13.0 | 2.7 | 8.1 | 2.4 |
| Dividend yield | — | — | — | — | — | 2.16% |
| 1-year change | +45.02% | +4.38% | +52.50% | +13.87% | +87.28% | +19.77% |
| Today | +1.81% | +8.37% | +6.64% | +9.69% | +2.76% | +2.89% |
The closest companies by business and industry (Medical Devices). Prices may be delayed up to 15 min.
Latest news
All SENS news ›Maryland’s Senseonics Begins First Human Study of Transmitter-Free Glucose Monitor
Germantown, Maryland-based Senseonics has begun its first human study of Freedom, an experimental continuous glucose monitoring (CGM) system designed to send glucose readings directly from an implanted sensor to a smartphone. The October…
Senseonics Holdings, Inc. to Participate in Upcoming Investor Conferences
WBOC TV 22, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc (NASDAQ: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for
Senseonics Bets a No-Money Deal With Beta Bionics Can Pull It Out of a Niche
What the deal does not include is the thing that usually matters most in medical-device partnerships: money. Senseonics CEO Tim Goodnow described it to Singh as "an integration," and declined to specify any economic terms. The partnership…
Senseonics: Eversense 365 Adoption Has To Earn The Valuation
Senseonics's Eversense 365 CGM drives sales and margin gains, but adoption, funding, dilution, and valuation risks remain. Click here for more on SENS stock. - Senseonics is rated Hold due to positive sales growth, margin improvement, and…
Beta Bionics, Inc. And Senseonics Announce Agreement To Integrate The iLet® Bionic Pancreas And mint? With Senseonics? Eversense® 365
Beta Bionics, Inc. announced a partnership to integrate the iLet Bionic Pancreas and mint automated insulin delivery systems with Senseonics? Eversense 365 continuous glucose monitoring system.... announced a partnership to integrate the…
Beta Bionics, Senseonics Partner to Integrate Diabetes Devices
Beta Bionics said Tuesday it partnered with Senseonics to integrate its iLet Bionic Pancreas and mint automated insulin delivery systems with Senseonics' Eversense 365 continuous glucose... Medical Equipment, Supplies & Distribution Beta…
Senseonics, Beta Bionics Partner on Eversense 365-iLet Diabetes System
Senseonics has partnered with Beta Bionics to integrate its Eversense 365 continuous glucose monitoring system with the iLet Bionic Pancreas automated insulin delivery system, the company said... Medical Equipment, Supplies & Distribution…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- marketscreener.com3
- finance.biggo.com1
- seekingalpha.com1
- wboc.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 6 articles, not a forecast.